Lexeo Therapeutics, Inc. reports JPMorgan's 5.5% stake.
- JPMorgan Chase & Co. owns 5.5% of Lexeo Therapeutics
- 4,573,701 shares beneficially owned
- JPMorgan is a Delaware-based entity
JPMORGAN CHASE & CO, filed by
LXEO
Lexeo Therapeutics, Inc. SEC filings
Every EDGAR filing for Lexeo Therapeutics, Inc. (LXEO), newest first, with AI summaries and stories.
- Ticker
- LXEO
- CIK
- 1907108
- Sector
- Biotech and pharma
- Latest filing
- 5d
Next: earnings expected ~Nov 12 · 10-Q expected ~Nov 12 (deadline Nov 16)
Insider activity
No open-market insider buys in the last 30 days.
Also: 3 grants or exercises.
Filings
SCHEDULE 13GLexeo Therapeutics, Inc.LXEOLIVE 8-KLexeo Therapeutics, Inc.LXEOLIVE 4Lexeo Therapeutics, Inc.LXEOLIVE 4 insider filings
Narinder Pal Bhalla, insider filing for LXEO
Show all 4
- 4Insider filing for LXEO
- 4Insider filing for LXEO
- 4Insider filing for LXEO
- 4Insider filing for LXEO
Narinder Pal Bhalla, reporting
8-KLexeo Therapeutics, Inc.LXEOLIVE 4Lexeo Therapeutics, Inc.LXEOLIVE 3 insider filings
Jose Manuel Otero, insider filing for LXEO
Show all 3
- 4Insider filing for LXEO
- 4Insider filing for LXEO
- 4Insider filing for LXEO
Jose Manuel Otero, reporting
144Lexeo Therapeutics, Inc.LXEOLIVE 3 Form 144 notices
Richard Nolan Townsend, planned sale of LXEO shares
Show all 3
- 144Planned insider sale of LXEO shares
- 144Planned insider sale of LXEO shares
- 144Planned insider sale of LXEO shares
Richard Nolan Townsend, reporting
SCHEDULE 13GLexeo Therapeutics, Inc.LXEOLIVE Ownership stake disclosure by ORBIMED ADVISORS LLC
ORBIMED ADVISORS LLC, filed by
SCHEDULE 13G/ALexeo Therapeutics, Inc.LXEOLIVE Ownership stake disclosure by Paradigm Biocapital Advisors LP (amended)
Paradigm Biocapital Advisors LP, filed by
SCHEDULE 13G/ALexeo Therapeutics, Inc.LXEOLIVE Ownership stake disclosure by BALYASNY ASSET MANAGEMENT L.P. (amended)
BALYASNY ASSET MANAGEMENT L.P., filed by
SCHEDULE 13G/ALexeo Therapeutics, Inc.LXEOLIVE Ownership stake disclosure by Affinity Asset Advisors, LLC (amended)
Affinity Asset Advisors, LLC, filed by
10-QLexeo Therapeutics, Inc.LXEOLIVE 8-KLexeo Therapeutics, Inc.LXEOLIVE SCHEDULE 13GLexeo Therapeutics, Inc.LXEOLIVE Ownership stake disclosure by STATE STREET CORP
STATE STREET CORP, filed by
4Lexeo Therapeutics, Inc.LXEOLIVE 4 insider filings
Louis Edward Tamayo, insider filing for LXEO
Show all 4
- 4Insider filing for LXEO
- 4Insider filing for LXEO
- 4Insider filing for LXEO
- 4Insider filing for LXEO
Louis Edward Tamayo, reporting
144Lexeo Therapeutics, Inc.LXEOLIVE 4 Form 144 notices
Jose Manuel Otero, planned sale of LXEO shares
Show all 4
- 144Planned insider sale of LXEO shares
- 144Planned insider sale of LXEO shares
- 144Planned insider sale of LXEO shares
- 144Planned insider sale of LXEO shares
Jose Manuel Otero, reporting
8-KLexeo Therapeutics, Inc.LXEOLIVE 4Lexeo Therapeutics, Inc.LXEOLIVE 7 insider filings
Steven Altschuler, insider filing for LXEO
Show all 7
- 4Insider filing for LXEO
- 4Insider filing for LXEO
- 4Insider filing for LXEO
- 4Insider filing for LXEO
- 4Insider filing for LXEO
- 4Insider filing for LXEO
- 4Insider filing for LXEO
Steven Altschuler, reporting
8-KLexeo Therapeutics, Inc.LXEOLIVE 4Lexeo Therapeutics, Inc.LXEOLIVE 2 insider filings
Richard Nolan Townsend, insider filing for LXEO
Show all 2
- 4Insider filing for LXEO
- 4Insider filing for LXEO
Richard Nolan Townsend, reporting
144Lexeo Therapeutics, Inc.LXEOLIVE 3 Form 144 notices
Richard Nolan Townsend, planned sale of LXEO shares
Show all 3
- 144Planned insider sale of LXEO shares
- 144Planned insider sale of LXEO shares
- 144Planned insider sale of LXEO shares
Richard Nolan Townsend, reporting
SCHEDULE 13G/ALexeo Therapeutics, Inc.LXEOLIVE Ownership stake disclosure by Paradigm Biocapital Advisors LP (amended)
Paradigm Biocapital Advisors LP, filed by
SCHEDULE 13G/ALexeo Therapeutics, Inc.LXEOLIVE Ownership stake disclosure by BALYASNY ASSET MANAGEMENT L.P. (amended)
BALYASNY ASSET MANAGEMENT L.P., filed by
10-QLexeo Therapeutics, Inc.LXEOLIVE 8-KLexeo Therapeutics, Inc.LXEOLIVE 4Lexeo Therapeutics, Inc.LXEOLIVE 2 insider filings
Laura Sepp-Lorenzino, insider filing for LXEO
Show all 2
- 4Insider filing for LXEO
- 3New insider at LXEO
Laura Sepp-Lorenzino, reporting
ARSLexeo Therapeutics, Inc.LXEOLIVE DEFA14ALexeo Therapeutics, Inc.LXEOLIVE